Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
04/06/2011 | CN102000121A Cordyceps militaris oligopeptide composition as well as preparation method and use thereof |
04/06/2011 | CN102000022A Recombined bifunctional plasmin freeze-drying preparation for injection and preparation method thereof |
04/06/2011 | CN101612114B Recombinant human interferon a2b suppository and preparation method thereof |
04/06/2011 | CN101497652B Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
04/06/2011 | CN101475936B EDRF gene fragment |
04/06/2011 | CN101457207B Eosinophil beta-mannanase MAN5A and gene and application thereof |
04/06/2011 | CN101417122B Recombination chicken alpha-interferon injection and preparation method thereof |
04/06/2011 | CN101412995B Polyethyleneglycol modified aprotinin and preparation thereof |
04/06/2011 | CN101337065B Use of MG132 in preparing medicine for synergistic inductive differentiation therapy of leukaemia |
04/06/2011 | CN101314032B Preparation technique for specified transfer factor oral preparation for typhoid fever, paratyphoid fever |
04/06/2011 | CN101302252B Extrasin alphal (Tal) analogue, production process and medical use thereof |
04/06/2011 | CN101270151B Peptide medicaments for accelerating medulla hematopoiesis cell proliferation |
04/06/2011 | CN101214375B Improved vaccines |
04/06/2011 | CN101147779B Composition containing nucleotide, its preparation method and its use |
04/06/2011 | CN101035805B Deglycosylated and desialidated long pentraxin PTX3 |
04/05/2011 | USRE42274 Cyclic peptide CXCR4 antagonists |
04/05/2011 | US7919612 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
04/05/2011 | US7919609 Toxins |
04/05/2011 | US7919606 Biological products |
04/05/2011 | US7919604 Fetal genes |
04/05/2011 | US7919592 Using microfiltration to remove microorganism from solution ccomprised of fibrinogen and/or antihemophilic factor |
04/05/2011 | US7919591 Modified human plasma polypeptide or Fc scaffolds and their uses |
04/05/2011 | US7919582 Neuregulin-β isoform |
04/05/2011 | US7919581 Bi-dentate compounds as kinase inhibitors |
04/05/2011 | US7919578 Methods and compositions for inhibition of BCL6 repression |
04/05/2011 | US7919577 Peptide analog with substitutions useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease; veterinary medicine, agriculture, aquaculture |
04/05/2011 | US7919478 Using vascular endothelial growth factor as wound healing agent; tissue engineering; regenerative medicine; wound healing agent |
04/05/2011 | US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
04/05/2011 | US7919471 Method of modulating cell survival and reagents useful for same |
04/05/2011 | US7919470 Glycopeptide composition with improved antibiotic activity |
04/05/2011 | US7919469 Methods and compositions for altering mucus secretion |
04/05/2011 | US7919468 Compounds useful as modulators of the proteasome activity |
04/05/2011 | US7919467 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
04/05/2011 | US7919466 Lymphatic zip codes in tumors and pre-malignant lesions |
04/05/2011 | US7919465 Peptide mimotopes that inhibits interaction between a platelet receptor and a platelet receptor ligand |
04/05/2011 | US7919464 Use of a peptide that interacts with αvβ3 integrin of endothelial cell |
04/05/2011 | US7919463 Growth-stimulating polypeptides for use in fish and crustaceans |
04/05/2011 | US7919462 Inhibitors of human plasmin derived from the Kunitz domains |
04/05/2011 | US7919461 Utilizing amino acid sequences linked to polyethylene glycol as agonists; increasing red blood cell production; chronic kidney disease |
04/05/2011 | US7919460 administering a prophylactically effective amount of natural calcitonin or a calcitonin derivative (elcatonin) to a stroke patient |
04/05/2011 | US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor |
04/05/2011 | US7919458 Method of inhibiting prostate cancer cell proliferation |
04/05/2011 | US7919456 Connective tissue derived polypeptides |
04/05/2011 | US7919455 Marked peptides having affinity for a phospholipid and uses |
04/05/2011 | US7919454 Methods of treating using conjugates transported by a PEPT2 transporter |
04/05/2011 | US7919329 Method for screening for agents that affect food intake |
04/05/2011 | US7919309 Method for expression of small antiviral RNA molecules within a cell |
04/05/2011 | US7919274 Detecting position of particle in cell; obtain cell, administer with light emitting fusion protein, detect signal, image signal |
04/05/2011 | US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
04/05/2011 | US7919118 Spacer moiety for poly (ethylene glycol) modified peptide based compounds |
04/05/2011 | US7919104 Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof |
04/05/2011 | US7919103 Compound and method for regulating plasminogen activation and cell migration |
04/05/2011 | US7919099 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
04/05/2011 | US7919098 ErbB-3 based methods and compositions for treating neoplasms |
04/05/2011 | US7919097 using a composition comprising a multimeric galectin-1 polypeptide; inflammatory bowel disease, food allergies or asthma; Crohn's disease or ulcerative colitis; multiple sclerosis, diabetes, rheumatoid arthritis, or systemic lupus erythematosis |
04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
04/05/2011 | US7919082 High-activity mutants of butyrylcholinesterase for cocaine hydrolysis and method of generating the same |
04/05/2011 | US7919078 Modified cytokine for use in treatment and prevention of viral infection, cell proliferative and autoimmune diseases |
04/05/2011 | US7919077 Pharmaceutical compositions comprising CCL2 and use of same for the treatment of inflammation |
04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
04/05/2011 | CA2461703C Modulation of physiological processes and agents useful for same |
04/05/2011 | CA2447909C Use of proteasome inhibitors to treat dry eye disorders |
04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
04/05/2011 | CA2429027C Antibodies against human receptor h4-1bb |
04/05/2011 | CA2379776C A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
04/05/2011 | CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
04/05/2011 | CA2309355C Tissue cement proteins from rhipicephalus appendiculatus |
04/05/2011 | CA2284547C Mu-opiate receptor peptides |
04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
04/05/2011 | CA2229163C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
04/02/2011 | CA2715959A1 Surgical compositions |
04/01/2011 | CA2697568A1 Cancer therapy |
03/31/2011 | WO2011038417A2 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation |
03/31/2011 | WO2011038293A1 Cyclic peptide inhibitors of hepatitis c virus replication |
03/31/2011 | WO2011038283A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
03/31/2011 | WO2011038259A1 Synthetic glycosyl hydrolase based on dna nanoweaves |
03/31/2011 | WO2011038149A2 Methods of treating inflammation |
03/31/2011 | WO2011038142A2 Bladder cancer specific ligand peptides |
03/31/2011 | WO2011038139A1 Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane |
03/31/2011 | WO2011038122A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
03/31/2011 | WO2011038054A1 COMPOSITIONS AND METHODS FOR INHIBITING Gα PROTEIN SIGNALING |
03/31/2011 | WO2011038049A1 Peptidomimetic macrocycles |
03/31/2011 | WO2011038015A1 Method of treating osteoporosis with a neurotoxin |
03/31/2011 | WO2011038014A2 Composition and method for treatment of diabetes |
03/31/2011 | WO2011038004A1 Methods and compositions for in-vivo enzyme capture |
03/31/2011 | WO2011038002A1 Immunogenic epitopes as targets for universal cancer vaccines |
03/31/2011 | WO2011037970A1 Podocyte ph modulation and uses thereof |
03/31/2011 | WO2011037859A2 Identification of antigenic peptides from multiple myeloma cells |
03/31/2011 | WO2011037760A2 Composite layered hemostasis device |
03/31/2011 | WO2011037483A1 Method for accelerating the development of mammalian livestock |
03/31/2011 | WO2011037157A1 Eye drops |
03/31/2011 | WO2011037058A1 Lactase preparation |
03/31/2011 | WO2011036665A2 Akt/mtorc1 pathway activators for use in increasing liver regeneration |
03/31/2011 | WO2011036487A1 Cancer therapy |
03/31/2011 | WO2011036444A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
03/31/2011 | WO2011036440A1 Antagonists of dsg2 for treatment of cancer |
03/31/2011 | WO2011036297A2 Method for the therapy and diagnosis of alzheimer's disease |
03/31/2011 | WO2011036174A1 A novel method for the production of a antimicrobial peptide |
03/31/2011 | WO2011035829A1 Pharmaceutical compositions for treating dysregulated inflammatory diseases |